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Using hyperpolarised NMR and DFT to rationalise
the unexpected hydrogenation of quinazoline to
3,4-dihydroquinazoline†‡
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PHIP and SABRE hyperpolarized NMR methods are used to follow
the unexpected metal-catalysed hydrogenation of quinazoline
(Qu) to 3,4-dihydroquinazoline as the sole product. A solution of
[IrCl(IMes)(COD)] in dichloromethane reacts with H2 and Qu to form
[IrCl(H)2(IMes)(Qu)2] (2). The addition of methanol then results in its
conversion to [Ir(H)2(IMes)(Qu)3]Cl (3) which catalyses the hydro-
genation reaction. Density functional theory calculations are used
to rationalise a proposed outer sphere mechanism in which (3)
converts to [IrCl(H)2(H2)(IMes)(Qu)2]Cl (4) and neutral [Ir(H)3(IMes)(Qu)2]
(6), both of which are involved in the formation of 3,4-dihydroquin-
azoline via the stepwise transfer of H+ and H, with H2 identified as the
reductant. Successive ligand exchange in 3 results in the production of
thermodynamically stable [Ir(H)2(IMes)(3,4-dihydroquinazoline)3]Cl (5).
The development and refinement of hyperpolarization methods
over the past 20 years has enhanced the power of nuclear
magnetic resonance (NMR) as a spectroscopic tool while leading
to clinical magnetic resonance imaging (MRI) applications.1–4
The most well-established of these techniques, dynamic nuclear
polarization (DNP), has been used in areas as diverse as materials
characterisation,5,6 mechanistic and kinetic studies of chemical
and enzymatic transformations by stopped flow DNP-NMR,7–9
and in vivo 1H, 13C and 15N monitoring.10–12 Other approaches
have exploited para-hydrogen ( p-H2) as an agent to transfer
polarization. para-Hydrogen Induced Polarization (PHIP)13 was
pioneered by Weitekamp,14,15 Bargon16 and Eisenberg,13,17 and
normally requires an unsaturated molecule to act as a hydrogen
acceptor. Reaction products formed by integrating protons
from the p-H2 are created with non-equilibrium nuclear spin
distributions and as a result yield greatly enhanced NMR
signals.18 This approach has been used widely to investigate
the reactivity of metal hydride complexes and probe their role in,
for example, metal catalysed hydrogenation19–21 and hydro-
formylation22–24 reactions. Other applications of PHIP have seen
p-H2 used to sensitize MRI studies,
25–28 to probe heterogeneous
reactions29–31 and metabolism32 and more recently to create
long-lived magnetic states.33–35
The requirement for chemical modification in PHIP has
been addressed through the Signal Amplification By Reversible
Exchange (SABRE) hyperpolarization method which, rather
than relying on the hydrogenation of an unsaturated substrate,
instead uses a metal complex as a chemical intermediary to
bring the sample into temporary contact with p-H2.
36–38 This
method has been shown to polarize a wide range of substrates,
leading to very large MR signal enhancements39 in the liberated
substrate. Theoretical treatments have rationalized this process
in terms of the J-coupling interactions that exist in these labile
complexes40,41 whilst subsequent developments have led to
the production of hyperpolarised long-lived singlet states using
SABRE.42,43
In this paper both PHIP and SABRE are used to follow the
unexpected metal-catalysed hydrogenation of quinazoline (Qu)
to 3,4-dihydroquinazoline. Density Functional Theory (DFT) is
combined with the experimental observations to rationalise a
proposed outer sphere mechanism for the reaction. The experi-
mental process starts with the reaction of a dichloromethane-d2
solution of [IrCl(COD)(IMes)], 1,44 (IMes = 1,3-bis(2,4,6-trimethyl-
phenyl)imidazole-2-ylidene and COD = cyclooctadiene) with Qu and
H2. Rather than yielding the Qu analogue of [Ir(H)2(IMes)(Qu)3]Cl
which forms from the analogous reaction with quinoline,45 neutral
[IrCl(H)2(IMes)(Qu)2] (2) forms according to Scheme 1. The
1HNMR
spectrum of 2 at 298 K yields two inequivalent hydride ligand
signals at d 22.84 (Ha, linewidth 16.7 Hz) and d 23.79
(Hb, linewidth 16.3 Hz). When p-H2 is employed as the reactant
at 253 K these two hydride resonances exhibit weak PHIP
enhancement37 which confirms their assignment as a pair of cis
hydride ligands. In addition, the proton resonances attributable
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to the Qu ligand trans to the hydrides as well as those of free
Qu show weak SABRE enhancement thus confirming the tran-
sient binding of the Qu ligand to the metal centre.
When this process is repeated at 298 K, the two hydride
ligands of 2 no longer exhibit PHIP, but all six of the free Qu
aromatic proton resonances exhibit SABRE, with the degree of
1H signal enhancement ranging from 61-fold for H8 to 108-fold
for H2. An average enhancement of 85-fold over all six protons
of Qu was achieved for a concentration of 1 of 5 mM with a
17-fold ligand excess (Fig. 1). Full characterisation and details
confirming the assignment of 2 to [IrCl(H)2(IMes)(Qu)2] are
given the ESI.‡
The fluxional behaviour of 2 in dichloromethane-d2 was
then probed by EXSY methods over the temperature range
263 to 299 K. Its inequivalent hydrides, Ha and Hb, were found
to interchange positions, with H2 elimination and dissociative
Qu loss also being detected. The H2 loss pathway shows a [H2]
dependence which is consistent with the involvement of the
intermediate [IrCl(H)2(Z
2-H2)(IMes)(Qu)] (4), a product that forms
when the ligand-dissociation-product [IrCl(H)2(IMes)(Qu)] is
trapped by H2 rather than Qu. This mechanism is consistent with
the reported H2 exchange pathway of IrCl(H)2(Z
2-H2)(PPr3
i)2.
47,48
The associated rate data from these studies yielded values for DH‡
and DS‡ of 87.8 1 kJ mol1 and 75 3 J K1 mol1, respectively,
for Quequatorial loss in accordance with a dissociative first step and
a relatively high Ir–N bond energy.46
DFT calculations were performed to corroborate the assign-
ment of 2. With dichloromethane solvation included at the PCM
continuum level, the calculations showed dispersion-corrected 2
to be 38.5 kJ mol1 more stable than [Ir(H)2(IMes)(Qu)3]Cl (3) at
298 K, consistent with the observation of 2 as the only reaction
product in dichloromethane. With methanol solvation however,
2 is predicted to be just 8.8 kJ mol1 more stable than 3 in
agreement with the expectation that charge-stabilizing methanol
increases the likelihood of formation of 3.
Prompted by this result, a further experiment was conducted
in which a dichloromethane-d2 solution of 1 containing a
20-fold excess of Qu and 50 ml of methanol-d4 was placed under
p-H2. As anticipated,
1H NMR signals due to 3 now dominate
with the six free Qu resonances showing substantial SABRE
signal gains. However, over the course of the next few hours, the
SABRE-enhanced NMR spectra showed dramatic changes that
signalled the exclusive conversion of Qu into 3,4-dihydro-
quinazoline,49–51 with no evidence for the formation of the
corresponding 1,2-dihydroquinazoline52 isomer (see ESI,‡ for
further details of the characterisation).
When the reaction was repeated in neat methanol-d4 (Fig. 2),
the SABRE 1H-NMR spectra initially show dominant hyper-
polarized signals for Qu but with minor signals due to 3,4-
dihydroquinazoline present from the start. This suggests that
the conversion of Qu to 3,4-dihydroquinazoline proceeds rapidly
under these conditions. While all seven ring protons of 3,4-
dihydroquinazoline show SABRE, no visible signal enhancement
is seen for its exchangeable NH proton. In addition to these
changes in the aromatic region, a single hydride signal emerges
from a complex array of peaks at d 23.6. This signal is
associated with the 3,4-dihydroquinazoline analogue of 3,
[Ir(H)2(IMes)(3,4-dihydroquinazoline)3]Cl (5), as characterised
by NMR and whose relatively greater stability than 3 was
validated by DFT (3 kJ mol1). This complex hydride resonance
behaviour reflects the formation of metal complex products
that feature varying proportions of 3,4-dihydroquinazoline and
quinazoline ligands with 5 the most stable of these and
Scheme 1 Solvent dependent reaction of 1 with quinazoline and H2 leads
to 2 in dichloromethane and unstable 3 in methanol-d4.
Fig. 1 Typical 1H NMR spectra of the aromatic region of a sample consist-
ing of Qu (0.1 M) and 1 (5 mM) in dichloromethane-d2: (A) magnetisation
at thermal equilibrium and (B) hyperpolarised magnetisation created by
SABRE at 65 G.
Fig. 2 Plot of a series of expansions of the aromatic region of five 1H NMR
spectra that track the conversion of quinazoline into 3,4-dihydroquinazoline
in methanol over a 24 h period.
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ultimately dominating the spectrum. At the completion of the
reaction, 5 delivers hyperpolarised signals for 3,4-dihydro-
quinazoline at d 7.1, 6.96, 6.88, 6.68 and 4.56 that exhibit
enhancement factors of 96-, 40-, 40-, 35- and 26-fold respec-
tively. Their average enhancements are lower than those of
quinazoline which is consistent with the DFT prediction that 5
is more stable than 3.
A series of control reactions were then used to probe this process
in more detail. In the first, the original dichloromethane-d2 solution
of 2 and Qu was heated under a H2 atmosphere overnight at 323 K
in the absence of methanol. No evidence for the hydrogenation of
Qu was observed and hence 2 cannot be involved in this process.
A direct inner sphere mechanism involving the stepwise inser-
tion of quinazoline into the Ir-H bonds of 3 might be predicted
but our DFT calculations suggest that this process has an
inhibiting energy barrier of4175 kJ mol1. A second possibility
involving transfer hydrogenation53–56 that works well with related
substrates57 would involve methanol as the proton source.58 In
order to identify the reductant, we placed a solution of 3 in pure
methanol under H2 and observed gradual conversion of quin-
azoline to 3,4-dihydroquinazoline. Replacing the H2 atmosphere
with N2 stopped the hydrogenation completely with no further
increases observed in the 3,4-dihydroquinazoline 1H NMR
signal over the following 24 h period. Subsequent addition
of ammonium formate, a known proton source for transfer
hydrogenation,59–61 failed to initiate any further hydrogenation,
even at 323 K, and so, on this basis, we conclude that the
reductant must be H2.
We note that hydrogenation of 2-methylquinoline has been
reported to take place via an outer sphere mechanism involving
an iridium dihydrogen dihydride complex.62,63 Such a mecha-
nism is consistent with our SABRE results and the dispersion-
corrected DFT calculations used here to underpin Scheme 2 (see
ESI‡). Thus, we propose a mechanism by which 3 first forms
[Ir(H)2(H2)(IMes)(Qu)2]Cl (4) (33 kJ mol
1 higher in energy than 3
as determined by the DFT calculations), before conversion to
neutral [Ir(H)3(IMes)(Qu)2] (6) and protonated quinazoline
(64.7 kJ mol1 higher in energy) via reaction intermediate
[Ir(H)2(IMes)(Qu)2  H  H  Qu]Cl. Hydride ligand transfer
then follows to form 3,4-dihydroquinazoline (overall reaction
exothermic by 33.7 kJ mol1 at 298 K). As the catalytic cycle
continues, successive ligand exchange in 3 results eventually in
the thermodynamically stable metal complex product, 5. The
importance of the choice of methanol as solvent in realising the
hydrogenation reaction lies in its role in stabilising 3 as a
product of the reaction of 1 with Qu and H2 rather than acting
as a proton source for the transfer hydrogenation step.
In summary, we have shown that 1H NMR spectroscopy com-
bined with SABRE can be used to follow the metal-catalysed
hydrogenation of quinazoline exclusively to 3,4-dihydroquinazoline.
While [IrCl(H)2(IMes)(Qu)2] (2) is unable to catalyse this transforma-
tion, the reaction proceeds readily via [IrCl(H)2(IMes)(Qu)3]Cl (3) with
[Ir(H)2(IMes)(3,4-dihydroquinazoline)3]Cl (5) the thermodynamically
favouredmetal complex product. The reductant in this process is H2,
and a solvent-dependent outer-sphere mechanism is proposed
which requires the formation of [Ir(H)2(H2)(IMes)(Qu)3]Cl (4) and
[Ir(H)3(IMes)(Qu)2] (6). Both 2 and 3 act as good SABRE catalysts with
quinazoline as substrate whilst 5 performs the same function with
3,4-dihydroquinazoline. All three of these complexes, when moni-
tored by NMR spectroscopy, show high levels of hyperpolarisation in
the heteroatom containing rings.
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